GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » EBITDA Margin %

Livzon Pharmaceutical Group (SZSE:000513) EBITDA Margin % : 26.74% (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Livzon Pharmaceutical Group's EBITDA for the three months ended in Mar. 2024 was ¥867 Mil. Livzon Pharmaceutical Group's Revenue for the three months ended in Mar. 2024 was ¥3,243 Mil. Therefore, Livzon Pharmaceutical Group's EBITDA margin for the quarter that ended in Mar. 2024 was 26.74%.


Livzon Pharmaceutical Group EBITDA Margin % Historical Data

The historical data trend for Livzon Pharmaceutical Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group EBITDA Margin % Chart

Livzon Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.58 27.65 23.00 24.39 26.75

Livzon Pharmaceutical Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.21 21.79 19.32 15.85 26.74

Competitive Comparison of Livzon Pharmaceutical Group's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Livzon Pharmaceutical Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Livzon Pharmaceutical Group's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Livzon Pharmaceutical Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Livzon Pharmaceutical Group's EBITDA Margin % falls into.



Livzon Pharmaceutical Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Livzon Pharmaceutical Group's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=3325.076/12430.038
=26.75 %

Livzon Pharmaceutical Group's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=867.243/3242.815
=26.74 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Livzon Pharmaceutical Group  (SZSE:000513) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Livzon Pharmaceutical Group EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Livzon Pharmaceutical Group (SZSE:000513) Business Description

Traded in Other Exchanges
Address
38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines